PATENT CLAIM ANALYSIS

Application Number: 15882400
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "094100"]

Abstract:
The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.

Claim (Index 1):
A medical device, comprising:\n an implant main body portion comprising a collagen-containing tissue matrix; and a transglutaminase coating disposed on at least a portion of an outer surface of the implant main body portion, wherein the coating provides at least one of an anti-adhesion or anti-abrasion property to the outer surface.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 86.0
- Lexical Diversity: 1.41667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13813814', '12231361', '10895961', '14696390', '13517906']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6773929492332104
- 35 USC 102 Novelty (BERT): 0.4936856387104554
- Combined Prediction Score: 0.6590222181809349
- Mean Citation Score: 156.113868
- Max Citation Score: 162.29962
- Similarity Product: 98.7344576943469

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test